C
IRON icon

Covestor’s Disc Medicine IRON Stock Holding History

Covestor’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
7
+5
+250% +$344 ﹤0.01% 2202
2026
Q1 		$0 Hold
2
– – ﹤0.01% 2515
2025
Q4 		$0 Hold
2
– – ﹤0.01% 2490
2025
Q3 		$0 Hold
2
– – ﹤0.01% 2507
2025
Q2 		$0 Hold
2
– – ﹤0.01% 2460
2025
Q1 		$0 Hold
2
– – ﹤0.01% 2466
2024
Q4 		$0 Hold
2
– – ﹤0.01% 2475
2024
Q3 		$0 Hold
2
– – ﹤0.01% 2456
2024
Q2 		$0 Sell
2
-8
-80% -$272 ﹤0.01% 2475
2024
Q1 		$1K Buy
10
+8
+400% +$519 ﹤0.01% 2004
2023
Q4 		$0 Hold
2
– – ﹤0.01% 2398
2023
Q3 		$0 Buy
+2
New +$100 ﹤0.01% 2386

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Covestor's IRON Position: Q2 2026 in Review

Covestor increased its Disc Medicine (IRON) stake by 250% in Q2 2026, buying an estimated $344 and bringing the position to 7 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2202.

Covestor first reported a position in IRON in Q3 2023 and has held it in 12 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Covestor held 7 shares of Disc Medicine worth $1K as of Q2 2026.
  • Covestor bought 5 Disc Medicine shares in Q2 2026, an estimated $344.
  • Disc Medicine made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2202 holding.
  • Covestor first reported a position in Disc Medicine in Q3 2023 and has held it in 12 quarters since.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.